Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Atropine improves insulin sensitivity in both lean and abdominally obese subjects.

Svensson MK, Jansson PA, Persson AL, Sjöstrand M, Eriksson JW.

J Clin Endocrinol Metab. 2011 Nov;96(11):E1843-7. doi: 10.1210/jc.2011-0669. Epub 2011 Aug 24.

PMID:
21865364
2.

Insulin clamp-derived measurements of insulin sensitivity and insulin secretion in lean and obese asian type 2 diabetic patients.

Suraamornkul S, Kwancharoen R, Ovartlarnporn M, Rawdaree P, Bajaj M.

Metab Syndr Relat Disord. 2010 Apr;8(2):113-8. doi: 10.1089/met.2009.0030.

PMID:
20059360
3.

Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.

Ferri C, Carlomagno A, Coassin S, Baldoncini R, Cassone Faldetta MR, Laurenti O, Properzi G, Santucci A, De Mattia G.

Diabetes Care. 1995 Feb;18(2):226-33.

PMID:
7729302
4.
5.

Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.

Kruszynska YT, Olefsky JM, Frias JP.

Metabolism. 2003 Feb;52(2):233-8.

PMID:
12601639
6.

Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.

Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H.

Diabetes. 1996 May;45(5):659-66. Erratum in: Diabetes 1996 Sep;45(9):1285.

PMID:
8621019
7.

What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?

Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman ET.

J Clin Endocrinol Metab. 2001 Mar;86(3):1020-5.

PMID:
11238480
8.

Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.

Kruszynska YT, Mulford MI, Baloga J, Yu JG, Olefsky JM.

Diabetes. 1998 Jul;47(7):1107-13.

PMID:
9648835
9.

Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.

Pendergrass M, Koval J, Vogt C, Yki-Jarvinen H, Iozzo P, Pipek R, Ardehali H, Printz R, Granner D, DeFronzo RA, Mandarino LJ.

Diabetes. 1998 Mar;47(3):387-94.

PMID:
9519744
10.

Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.

Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J.

Diabetes. 1995 Sep;44(9):1121-5.

PMID:
7657038
11.

Nicotine infusion acutely impairs insulin sensitivity in type 2 diabetic patients but not in healthy subjects.

Axelsson T, Jansson PA, Smith U, Eliasson B.

J Intern Med. 2001 Jun;249(6):539-44.

12.

Early phase insulin infusion and muscarinic blockade in obese and lean subjects.

Teff KL, Townsend RR.

Am J Physiol. 1999 Jul;277(1 Pt 2):R198-208.

13.

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA.

Gastroenterology. 2007 Aug;133(2):496-506. Epub 2007 May 1.

PMID:
17681171
14.

NIDDM in the elderly.

Meneilly GS, Elliott T, Tessier D, Hards L, Tildesley H.

Diabetes Care. 1996 Dec;19(12):1320-5.

PMID:
8941457
15.

Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesity.

Maier C, Riedl M, Vila G, Nowotny P, Wolzt M, Clodi M, Ludvik B, Luger A.

Diabetes. 2008 Sep;57(9):2332-40. doi: 10.2337/db07-0758. Epub 2008 Jun 20.

16.

Chitosan improves insulin sensitivity as determined by the euglycemic-hyperinsulinemic clamp technique in obese subjects.

Hernández-González SO, González-Ortiz M, Martínez-Abundis E, Robles-Cervantes JA.

Nutr Res. 2010 Jun;30(6):392-5. doi: 10.1016/j.nutres.2010.06.005.

PMID:
20650346
17.

A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.

Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ.

Diabetes Care. 2001 Mar;24(3):539-48. Erratum in: Diabetes Care. 2014 Jul;37(7):2063.

PMID:
11289482
18.

The effects of short-term overfeeding on insulin action in lean and reduced-obese individuals.

Cornier MA, Bergman BC, Bessesen DH.

Metabolism. 2006 Sep;55(9):1207-14.

PMID:
16919540
19.

Autonomic blockade improves insulin sensitivity in obese subjects.

Gamboa A, Okamoto LE, Arnold AC, Figueroa RA, Diedrich A, Raj SR, Paranjape SY, Farley G, Abumrad N, Biaggioni I.

Hypertension. 2014 Oct;64(4):867-74. doi: 10.1161/HYPERTENSIONAHA.114.03738. Epub 2014 Jul 7.

20.

Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.

Chung JW, Suh KI, Joyce M, Ditzler T, Henry RR.

Diabetes Care. 1995 May;18(5):666-73.

PMID:
8586004

Supplemental Content

Support Center